Skip To Main Content
C. Sofocleous on Muck Rack

C. Sofocleous

As seen in: Journal of Interventional Radiology (JVIR)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to C. Sofocleous’s profile

Articles by C. Sofocleous

Abstract No. 90 Long-Term Outcomes of PET-Guided Microwave Ablation of Breast Cancer Liver Metastases

|
By D. Sarkar, C. Sofocleous, V. Sotirchos, E. Ziv
| Journal of Interventional Radiology (JVIR) Verified
Abstract No. 89 Safety, Technical Success, and Clinical Outcomes of Percutaneous Cryoablation of Central Renal Tumors without Pyeloperfusion in 94 Patients
Open in Who Shared Issue with article?
|
By V. Sotirchos, E. Vakiani, E. Ziv, H. Kunin, J. Erinjeri, S. Solomon, C. Sofocleous, H. Kunin, M. Silk
| Journal of Interventional Radiology (JVIR) Verified
The presence of residual viable tumor cells in ablation zone biopsies has been shown to predict shorter local tumor progression-free survival (LTPFS). The purpose of this study was to evaluate if the Ki-67 labeling index (LI), as assessed on immediate pre-ablation biopsies of colorectal cancer liver metastases (CLM), is associated with the presence of viable tumor cells in the ablation zone and/or local tumor recurrence.
Open in Who Shared Issue with article?
|
By J. Erinjeri, S. A. Shah, H. Yarmohammadi, N. Kastango, E. Ziv, E. J. Alexander, K. Zhao, F. Cornelis, F. Ridouani, E. Santos, C. Sofocleous, S. Solomon, N. Kastango, V. Sotirchos, Y. Bryce
| Journal of Interventional Radiology (JVIR) Verified
Abstract No. 255 Impact of VIR operations in a hospital length of stay (LOS): an analysis of causation, length, and cost
Open in Who Shared Issue with article?

Abstract No. 19 Optimal timing of cytotoxic chemotherapy when combined with thermal ablation of liver metastases

|
By A. P. Maxwell, C. Sofocleous, S. Solomon, N. Kemeny
| Journal of Interventional Radiology (JVIR) Verified
Adjuvant versus neoadjuvant chemotherapy has been extensively discussed in the surgical literature, but much less is known about the optimal timing of peri-ablation chemotherapy. Here, we examine whether the timing of peri-ablation chemotherapy (adjuvant versus neoadjuvant) affects outcomes.
Open in Who Shared Issue with article?

03:18 PM Abstract No. 433 Hepatotoxicity after radioembolization for liver metastases due to breast cancer in the setting of systemic therapy

|
By S. R. Kulkarni, Budd Lake, H. Yarmohammadi, C. Sofocleous
| Journal of Interventional Radiology (JVIR) Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. To describe the hepatotoxicity of radioembolization (RE) for liver metastasis in breast cancer (BC) patients on systemic therapy.
Open in Who Shared Issue with article?
Show More